| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 2.226 | 5.849 | 6.664 | 2.582 | 1.474 | 152 | 91 | 30 |
| Total Income - EUR | - | 0 | 2.226 | 5.849 | 6.664 | 2.582 | 1.474 | 152 | 91 | 30 |
| Total Expenses - EUR | - | 0 | 9.436 | 8.507 | 9.639 | 4.664 | 1.020 | 1.090 | 2.097 | -54 |
| Gross Profit/Loss - EUR | - | 0 | -7.210 | -2.658 | -2.975 | -2.081 | 454 | -938 | -2.006 | 85 |
| Net Profit/Loss - EUR | - | 0 | -7.239 | -2.705 | -3.025 | -2.115 | 421 | -941 | -2.007 | 80 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vdmy Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 852 | 752 | 654 | 566 | 497 | 413 | 372 | 370 |
| Current Assets | - | 0 | 9 | 1.283 | 1.522 | 301 | 85 | 44 | 3 | 33 |
| Inventories | - | 0 | 0 | 1.283 | 1.522 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 0 |
| Cash | - | 0 | 9 | 0 | 0 | 301 | 85 | 33 | 3 | 33 |
| Shareholders Funds | - | 0 | -7.974 | -10.532 | -13.353 | -15.215 | -14.456 | -15.442 | -17.402 | -17.225 |
| Social Capital | - | 0 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 0 | 8.835 | 12.567 | 15.529 | 16.082 | 15.038 | 15.899 | 17.778 | 17.629 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Vdmy Medical Srl